Publications

• The impact of perioperative stroke and delirium on outcomes after surgical aortic valve replacement.
  Volume: 167 Page(s): 624 - 633.e4
  02/01/2024 Authors: Mess SR; Overbey JR; Thourani VH; Moskowitz AJ; Gelijns AC; Groh MA; Mack MJ; Ailawadi G; Furie KL; Southerland AM
• Risk for non-home discharge following surgery for ischemic mitral valve disease.
  J Thorac Cardiovasc Surg Volume: 162 Page(s): 1769 - 1778.e7
  12/01/2021 Authors: Lala A; Chang HL; Liu X; Charles EJ; Yerokun BA; Bowdish ME; Thourani VH; Mack MJ; Miller MA; O'Gara PT
• Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation.
  J Am Coll Cardiol Volume: 77 Page(s): 713 - 724
  02/16/2021 Authors: Bertrand PB; Overbey JR; Zeng X; Levine RA; Ailawadi G; Acker MA; Smith PK; Thourani VH; Bagiella E; Miller MA
• Experience With Cardiology-Oriented Outcomes in Critically Ill Patients With Coronavirus Disease 2019.
  Crit Care Explor Volume: 2 Page(s): e0288
  12/01/2020 Authors: Connor-Schuler R; Wong AI; Shah A; Fiza B; Lyle M; Ramonell R; Hockstein M; Chang G; Markham D; Searles C
• Cost-effectiveness of coronary artery bypass grafting plus mitral valve repair versus coronary artery bypass grafting alone for moderate ischemic mitral regurgitation.
  J Thorac Cardiovasc Surg Volume: 159 Page(s): 2230 - 2240.e15
  06/01/2020 Authors: Ferket BS; Thourani VH; Voisine P; Hohmann SF; Chang HL; Smith PK; Michler RE; Ailawadi G; Perrault LP; Miller MA
• Usefulness of Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease.
  Am J Cardiol Volume: 124 Page(s): 1785 - 1789
  12/01/2019 Authors: Thobani A; Dhindsa DS; DeMoss BD; Raad M; Sandesara PB; Sperling LS; Baer JT
• Secondary surgical-site infection after coronary artery bypass grafting: A multi-institutional prospective cohort study.
  J Thorac Cardiovasc Surg Volume: 155 Page(s): 1555 - 1562.e1
  04/01/2018 Authors: Gulack BC; Kirkwood KA; Shi W; Smith PK; Alexander JH; Burks SG; Gelijns AC; Thourani VH; Bell D; Greenberg A
• Life's Simple 7 Approach to Atrial Fibrillation Prevention.
  J Atr Fibrillation Volume: 11 Page(s): 2051
  01/01/2018 Authors: Isakadze N; B P; B S; Patel R; Baer J; Isiadinso I; Alonso A; Lloyd M; Sperling L
• Current Treatment of Familial Hypercholesterolaemia.
  Eur Cardiol Volume: 9 Page(s): 76 - 81
  12/01/2014 Authors: Lambert CT; Sandesara P; Isiadinso I; Gongora MC; Eapen D; Bhatia N; Baer JT; Sperling L
• Cardiometabolic Recovery Kinetics Post Apheresis in a Model of Accelerated Atherothrombosis
  Volume: 111
  08/03/2012 Authors: Bhatia NK; Patel A; Ramjee V; Epperson M; Ngoc-Anh L; Vaughn L; Nell-Dybdahl C; Baer J; Wilson P; Sperling L
• Niacin and statin combination therapy for atherosclerosis regression and prevention of cardiovascular disease events: reconciling the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) trial with previous surrogate endpoint trials.
  J Am Coll Cardiol Volume: 59 Page(s): 2058 - 2064
  06/05/2012 Authors: Michos ED; Sibley CT; Baer JT; Blaha MJ; Blumenthal RS
• INFLAMMATORY AND LIPID MARKERS PRE- AND POST-LDL APHERESIS IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (THE INFLAME STUDY)
  Volume: 59 Page(s): E1385 - E1385
  03/27/2012 Authors: Ramjee V; Epperson M; Le N-A; Vaughn L; Baer J; Nell-Dybdahl C; Wilson P; Sperling L
• High-density lipoprotein therapy: is there hope?
  Curr Treat Options Cardiovasc Med Volume: 12 Page(s): 315 - 328
  08/01/2010 Authors: Bhatt KN; Wells BJ; Sperling LS; Baer JT
• Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS).
  Am J Cardiol Volume: 104 Page(s): 1457 - 1464
  12/01/2009 Authors: Zhao X-Q; Krasuski RA; Baer J; Whitney EJ; Neradilek B; Chait A; Marcovina S; Albers JJ; Brown BG
• Low-density lipoprotein apheresis as a treatment option for hyperlipidemia.
  Curr Treat Options Cardiovasc Med Volume: 11 Page(s): 279 - 288
  08/01/2009 Authors: Mehta PK; Baer J; Nell C; Sperling LS
• Hypervitaminosis A altering the lipid profile in a hypercholesterolemic patient.
  J Clin Lipidol Volume: 3 Page(s): 205 - 207
  01/01/2009 Authors: Yehya A; Baer JT; Smiley W; Dollar A; Sperling L
• Class effect of angiotensin-converting enzyme inhibitors on prevention of myocardial infarction.
  Am J Cardiol Volume: 94 Page(s): 1171 - 1173
  11/01/2004 Authors: Sauer WH; Baer JT; Berlin JA; Kimmel SE
• Comparison of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of myocardial infarction in hypertensive patients.
  Am J Cardiol Volume: 94 Page(s): 479 - 481
  08/15/2004 Authors: Baer JT; Sauer WH; Berlin JA; Kimmel SE
• Angiotensin-converting enzyme inhibitors are comparable to angiotensin II receptor blockers in the primary prevention of myocardial infarction in hypertensive patients
  Volume: 43 Page(s): 531A - 531A
  03/03/2004 Authors: Baer JT; Sauer WH; Berlin JA; Kimmel SE
• The imperative for quality: a call for action to medical schools and teaching hospitals.
  Acad Med Volume: 78 Page(s): 1085 - 1089
  11/01/2003 Authors: Academic Medical Center Working Group of the Institute for Healthcare Improvement
• Nuclear factor-kappaB activation in endothelium by Chlamydia pneumoniae without active infection.
  J Infect Dis Volume: 188 Page(s): 1094 - 1097
  10/15/2003 Authors: Baer JT; Du Laney TV; Wyrick PB; McCain AS; Fischer TA; Merricks EP; Baldwin AS; Nichols TC
• Rheumatoid arthritis is not associated with myocardial infarction after controlling for other risk factors
  Volume: 41 Page(s): 305A - 305A
  03/19/2003 Authors: Baer JT; Berlin JA; Albert DA; Kimmel SE
• Investigation of a suspected outbreak of vaginal trichomoniasis among female inmates.
  Sex Transm Dis Volume: 26 Page(s): 335 - 338
  07/01/1999 Authors: Klausner JD; Baer JT; Contento KM; Bolan G
• HIV infection as a risk factor for shigellosis.
  Emerg Infect Dis Volume: 5 Page(s): 820 - 823
  01/01/1999 Authors: Baer JT; Vugia DJ; Reingold AL; Aragon T; Angulo FJ; Bradford WZ